Hambrecht & Quist Capital Management »

Avantor shares owned by Hambrecht & Quist Capital Management

Quarter-by-quarter ownership of Avantor (AVTR) shares owned by Hambrecht & Quist Capital Management from 13F filings

Historical chart of Hambrecht & Quist Capital Management investment in Avantor

Tip: Access up to 7 years of quarterly data

All positions including Avantor held by Hambrecht & Quist Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avantor by Hambrecht & Quist Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $9.4M 460k 20.54
2023-03-31 $9.7M 460k 21.14
2022-12-31 $9.7M 460k 21.09

More positions owned by Hambrecht & Quist Capital Management

Amgen Common (AMGN)
Johnson & Johnson Common (JNJ)
Gilead Sciences Common (GILD)
Regeneron Pharmaceuticals Common (REGN)
Vertex Pharmaceuticals Common (VRTX)
Eli Lilly and Company Common (LLY)
Unitedhealth Group Common (UNH)
Merck & Co Common (MRK)
AbbVie Common (ABBV)
Biogen Common (BIIB)
AstraZeneca Sponsored ADR (AZN)
Illumina Common (ILMN)
Abbott Laboratories Common (ABT)
Pfizer Common (PFE)
Thermo Fisher Scientific Common (TMO)

View all positions for Hambrecht & Quist Capital Management

Top funds holding Avantor

Vanguard Group
Dodge & Cox
Robeco Investment Management
Barrow, Hanley, Mewhinney & Strauss
T. Rowe Price Associates
Henderson Group
New Mountain Capital
Millennium Management
Artemis Investment Management
Ubs Global Asset Management Americas
Parnassus Investments
Norges Bank Investment Management
Bessemer
Clarkston Capital Partners
SAM Sustainable Asset Management

View all funds holding Avantor